JSP Pharmaceutical Manufacturing Thailand Public : Establishment of a new subsidiary
June 28, 2022 at 11:41 am EDT
Share
(
)
(
)
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED
No. JPCS-22/010
Date: 28 June 2022
Re:
Establishment of a new subsidiary
To
Director and manager, The Stock Exchange of Thailand
JSP Pharmaceutical Manufacturing (Thailand) PCL. ("the Company") would like to inform the resolution of the Board of Directors meeting no. 4/2022 on 28 June 2022, which significant resolution was approval of a new subsidiary establishment with details as follow:
The date on which the Board of Directors
28
June 2022
passed its resolution
The expected date of the establishment
Within August 2022
of subsidiary company
Company name
Caresutic Company Limited
Objectives
To generate revenue and profit apart from core business
Business description
(1)
Innovation Center to perform research and development
in dietary supplements and cosmetics
(2)
Small-scale production facility of dietary supplements
and cosmetics
Registered capital, number of shares and
Baht 5.00 million, divided to be 50,000 shares with par value
par value
of Baht 100 per share
Shareholding proportion
The Company will hold 99.99% ownership interest of the
authorised capital
Name of directors
(1)
Mrs. Jintana Santipisud
(2)
Mr. Sittichai Daengprasert
(3)
Ms. Jirada Daengprasert
Source of fund for establishment of
The Company's working capital
subsidiary company
To compute transaction size, the Company used financial information presented in the Company's interim financial information as of 31 March 2022. The highest transaction size was 0.54% based on net tangible assets. In connection with acquisition of assets in the last six months, the highest transaction size was 11.15% based on total value of consideration. In conclusion, this transaction is not required to perform under the
(
)
(
)
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED
Notification of the Capital Market Supervisory Board No. Tor Chor 20/2551 and is not a connected transaction. However, this transaction is considered as acquisition of investment in other company; which results other company becomes a subsidiary of a listed company, in accordance with the Regulations of the Stock Exchange of Thailand Re: Rules, Conditions and Procedures Governing the Disclosure of Information and Other Acts of a Listed Company.
Please be informed accordingly.
Sincerely yours,
JSP Pharmaceutical Manufacturing (Thailand) PCL.
Mr. Kriangkrai Rungruangthaweekul
Vice President of Finance
Investor Relations
Tel. 064 479 1691
Emailir@jsppharma.com
Attachments
Original Link
Original Document
Permalink
Disclaimer
JSP Pharmaceutical Manufacturing Thailand pcl published this content on 28 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2022 15:40:18 UTC.
JSP Pharmaceutical Manufacturing (Thailand) PCL is a Thailand-based company, which manufactures and distributes conventional medicines. The Company manufactures and distributes products under customerâs brand name (OEM), as well as under the Companyâs brand name. The Company develops, manufactures and sells conventional and traditional medicines, herbal products and dietary supplements, providing a range of services covering the manufacturer and the seller of the products under both customersâ trademark (OEM) and the seller of the products under the Companyâs trademark (Own Brand). The Company develops herbal products, dietary supplements with natural extracts and plant-based protein under brand name Supap Osot, and dietary supplements such as using new raw materials or having new production process for both beauty and health under brand name EVITON. The Companyâs subsidiary, Caresutic Co., Ltd., is engaged in manufacturing and distribution of dietary supplements and cosmetic products.
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC CO., LTD. 
